The Adam Smith Ukrainian Pharmaceutical Forum took place on 14th – 15th October 2008 at the Premier Palace Hotel in Kyiv, and proved to be a very timely and productive gathering of the most senior figures in the Ukrainian pharmaceutical sector, and their international counterparts.

An impressive number of attendees took part in the 2-day conference. They had the opportunity to hear from our high-profile speakers panel, which, amongst others featured the following representatives:

Victor Chumak, Director, State Pharmacological Centre, Ministry of Healthcare of Ukraine

Konstantin Kosyachenko, Deputy Head, Public Office for Pharmaceuticals and Medical Products

Viktor Shafransky, Chairman, Association of Pharmaceutical Research and Development (APRaD); General  Manager, Representative Office Ipsen Ukraine

Vladislav Strashny, General Manager, Representation Office Pfizer H.C.P. Corporation; Co-Chairman, Healthcare Committee, American Chamber of Commerce in Ukraine

Volodymyr Mitin, Head, Actavis Representative Office in Ukraine

Alexandra Sologub, Chief Representative, Teva Pharmaceuticals

Dr. Sabine Vogler, Pharmaceutical Pricing and Reimbursement Information, Austrian Health Institute

Sergey Sur, Research and Product Development Director, Arterium Corporation

Eugene Zaika, Country Manager, NYCOMED in Ukraine and Moldova

Particular attention was paid to the leading strategies driving the development of Ukrainian pharmaceutical sector, the most timely issues and challenges facing companies today, as well as to the discussion of industry forecasts – views were expressed by representatives of regulatory bodies, as well as key market participants. The audience heard not only thought-provoking case studies but had the opportunity to take part in numerous interactive panel discussions on the burning issues of the moment.

The forum attracted top executives from leading domestic and international companies from 15 countries, including such renowned companies as:

Actavis* Advent International* Alba Ukraine* Alfa Wassermann* Alliance Boots* Arterium Corporation* Artur-K* Astellas Pharma Europe BV* AstraZeneca* Bayer Schering Pharma* BELUPO* Berlin-Chemie AG* Biocon* Borshchahivskiy Chemical-Pharmaceutical Plant* Darnitsa* EBEWE Pharma* EGIS* Farmak* Ferring Pharmaceuticals* Fitofarm* Grindeks* Hansa Company* Interkhim* Jadran* Jelfa* Johnson & Johnson* Jubilant Pharmaceuticals* Kiev Vitamin Plant* Lekhim* Linda-Farm* Lupin Limited* Max-Well* MedService Group* Nizhpharm* Novartis Consumer Health Services* Nycomed* Orion Pharma* Pfizer H.C.P. Corporation* PLIVA Ukraine* Polpharma* Schering-Plough Central East AG* Servier Ukraine LLC* Solvay Pharma* Sopharma Plc* Stirolbiopharm* Teva Pharmaceuticals* Unipharm AD* Vitalux Pharmasy Chain* VVS Ltd* Zdravitsa Pharmacy

and many others…

Delegates also appreciated the innovative features, designed to enhance networking opportunities, including:

• INTERACTIVE WORKGROUP: UKRAINIAN PHARMACEUTICAL MARKET DEVELOPMENT - STRATEGIC POINT OF VIEW
  
  
• INTERVIEW WITH Vladislav Strashny, General Manager of Representation Office, Pfizer H.C.P. Corporation Ukraine
  
  
• 2 SPOTLIGHT PRESENTATIONS: Overview of current pricing and reimbursement schemes in the pharmaceutical sector
  
  
• INTERACTIVE FOCUS: DISCUSSION WITH THE REGULATORS
  
  
• In partnership with

SPECIAL PARTNER SECTION: INVESTMENT OPPORTUNITIES IN THE UKRAINIAN HEALTHCARE SECTOR

A big thank you is extended to all speakers, sponsors and attendees of the event.